APOBEC3B and breast cancer: Epidemiological combined with experimental data have demonstrated that (i) the prevalence of high-risk HPVs is high in early as compared to late breast cancer, (ii) this early influence of HPVs is indirect and operates by the destabilizing effects of HPV on the human genome via APOBEC3B enzyme (38).